
### [NCIT:C40181](http://purl.obolibrary.org/obo/NCIT_C40181)
**Label:** Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

**Subclasses:** [NCIT:C6336](http://purl.obolibrary.org/obo/NCIT_C6336) (Uterine Corpus Adenosarcoma), [NCIT:C6335](http://purl.obolibrary.org/obo/NCIT_C6335) (Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C6338](http://purl.obolibrary.org/obo/NCIT_C6338) (Uterine Corpus Adenomyoma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma), [NCIT:C6311](http://purl.obolibrary.org/obo/NCIT_C6311) (Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), 

**Class expressions from DL-Learner:**

- [UBERON:0009853](http://purl.obolibrary.org/obo/UBERON_0009853) (body of uterus) 55.00%
- [UBERON:0000995](http://purl.obolibrary.org/obo/UBERON_0000995) (uterus) 55.00%
- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 55.00%
- Thing 53.22%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13207](http://purl.obolibrary.org/obo/NCIT_C13207) (Chromosome 12))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13206](http://purl.obolibrary.org/obo/NCIT_C13206) (Chromosome 11))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13205](http://purl.obolibrary.org/obo/NCIT_C13205) (Chromosome 10))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13204](http://purl.obolibrary.org/obo/NCIT_C13204) (Chromosome 1))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C132018](http://purl.obolibrary.org/obo/NCIT_C132018) (MYC Gene Rearrangement))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13201](http://purl.obolibrary.org/obo/NCIT_C13201) (Chromatin))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C13197](http://purl.obolibrary.org/obo/NCIT_C13197) (Nucleus))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C131913](http://purl.obolibrary.org/obo/NCIT_C131913) (High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C131906](http://purl.obolibrary.org/obo/NCIT_C131906) (EBV-Positive Mucocutaneous Ulcer))) 40.36%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C131875](http://purl.obolibrary.org/obo/NCIT_C131875) (Recurrent Childhood T Acute Lymphoblastic Leukemia))) 40.36%


